Entry tags:
This Deserves Its Own Post
http://money.cnn.com/news/newsfeeds/articles/apwire/0100f22694e88c793f51b43295ec9a85.htm
http://www.marketwatch.com/news/story/Hologic-Releases-Results-CervistaTM-HPV/story.aspx?guid=%7B8131E2BB-A74F-4790-BBA9-17BA35200803%7D
A new test created by Hologic for detecting the 14 types of HPV that cause cancer in women over age 30 has shown "100 PERCENT ACCURACY at detecting the HPV strain that poses the highest risk of cancer. Cervista showed 92 percent accuracy at detecting a second strain that is often linked to cervical cancer."
The proposed use of this test is as a general screen for HPV in combination with a pap test for women over 30.
And a competing company, AVC, has also come out with an HPV test:
http://www.marketwatch.com/news/story/Arbor-Vita-Presents-New-Data/story.aspx?guid=%7BA2481E52-E0C5-43DC-A706-9E233DE7D418%7D
(There was a conference in Europe today where a bunch of companies unveiled their latest findings, which is why I'm getting all these HPV updates today)
no subject
no subject
no subject
no subject
no subject
They're not giving too many technical details, but we have had an HPV test for a few years now that did not work on men for some reason, so I assume that whatever mechanism that test used, these are similar.
The second new test, from the AVC company, is specifically for cervical cancer, which does not apply to men. The test is engineered to specifically detect E6 oncoprotein of high-risk HPV which, in concert with E7, is necessary for oncogenic transformation of cervical epithelial cells. That link gives much more in-depth detail about what the test entails.